Acta Labs

Acta Labs

Helping health technologies move from promise to practice.

Acta Labs builds practical tools for early health technology questions: what has been proven, what stage the technology is in, what evidence is appropriate for that stage, and what would be needed before the next step.

Get in touch →

Tools

Two practical tools for health technology development, evidence planning, and real-world translation.

Use them when a diagnostic, AI health tool, digital health product, workflow, or data-driven technology looks promising, but the next step is unclear.

AssessMapApply

Health Tech Readiness Lab

Assess whether a health technology is ready to move forward.

Work through the technology's claim, evidence, development stage, intended users, use case, risks, and next decision.

It helps clarify

  • What has been proven?
  • What has not been proven yet?
  • Is the evidence appropriate for this stage?
  • What decision could the evidence support?
  • What would be needed before moving forward?

Real-World Translation Canvas

Map what would need to be true for a technology to work in practice.

Think through the path from early promise to pilot, adoption, implementation, or scale.

It helps clarify

  • Who would use the technology?
  • Where would it fit into existing workflows?
  • What evidence would matter to adopters?
  • What operational barriers could block use?
  • What would need to happen next?

Why Acta Labs exists

Technology Readiness Levels helped teams ask whether a technology was mature enough to move forward, and that question still matters. In health technology, though, a single technical scale is rarely enough. Diagnostics, software, AI health tools, digital workflows, and data products each require different kinds of evidence at different stages of development.

A lab result, prototype, pilot, model output, workflow test, or real-world dataset may each be useful, but they do not answer the same question.

Acta Labs tools help work through what the evidence shows, what it does not yet show, and what would be needed before the technology is ready for a pilot, partnership, funding decision, adoption pathway, or scale.

Traditional readiness

Can the technology work?

Health tech readiness

What has been proven, for whom, in what setting, and what next step does that evidence support?

ActOnDx

Applied project: follow-up management for high-risk diagnostic pathways.

ActOnDx is the first applied project from Acta Labs. It applies the same evidence-to-practice approach to one concrete problem: what happens after a diagnostic result is flagged.

ActOnDx helps teams coordinate the next step, track follow-up over time, keep patients informed, and document resolution.

Flagged resultClinical actionDocumented resolution

For more information, visit www.actondx.com.

Discuss ActOnDx

About

Portrait of Anastasia Liapis, PhD, founder of Acta Labs

Acta Labs was created by Anastasia Liapis, PhD, after more than a decade working across molecular diagnostics, startup fundraising, acquisition, post-acquisition integration, and corporate health innovation.

Her background spans product strategy for clinical and diagnostic technologies, evidence generation, strategic partnerships, product definition, and early-stage health technology development.

Across those settings, the same question kept coming up: what evidence is enough for this stage, what does it actually prove, and what would a funder, partner, pilot site, or adopter need to see before moving forward?

Acta Labs brings that work into one place: practical tools, applied projects, and early-stage concepts focused on health technology readiness, evidence planning, and real-world translation.

Connect on LinkedIn

Contact

If you are working on a diagnostic, AI health tool, digital health product, evidence question, or health technology innovation problem, I'd be glad to hear from you.

Pressing send opens your email client. Nothing is submitted to Acta Labs.

Your answers stay in your browser while you use the tools. They are not stored, submitted, or sent to Acta Labs. If you email or share your results, that happens through your own email or LinkedIn account.